Media Resources

Variant Corporate Fact Sheet, Q4-2017

Management Team

Hydroxypropyl Beta Cyclodextrin (HPβCD) Backgrounder

Therapeutic Backgrounder: Focal Segmental Glomerulosclerosis (FSGS)

Therapeutic Backgrounder: Alport Syndrome (AS)

Corporate Logos